Xtl Bio Statistics
Xtl Bio (XTLB) Stock Statistics & Valuation Metrics
Total Valuation
Xtl Bio has a market cap or net worth of ILA 25.11M. The enterprise value is ILA 5.24T.
- Market Cap
- ILA 25.11M
- Enterprise Value
- ILA 5.24T
Share Statistics
Xtl Bio has 1,793,390,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,793,390,500
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Xtl Bio’s return on equity (ROE) is 27.44 and return on invested capital (ROIC) is -11253.33%.
- Return on Equity (ROE)
- 27.44
- Return on Assets (ROA)
- -41.98
- Return on Invested Capital (ROIC)
- -11253.33%
- Return on Capital Employed (ROCE)
- 6.65
- Revenue Per Employee
- 0
- Profits Per Employee
- -696.90K
- Employee Count
- 10
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Xtl Bio is -0.54. Xtl Bio’s PEG ratio is 0.01.
- PE Ratio
- -0.54
- PS Ratio
- 0.00
- PB Ratio
- -15.35
- Price to FCF
- -4.17
- Price to Operating Cash Flow
- -3.80
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Xtl Bio had revenue of 0 and earned -6.97M in profits. Earnings per share was -0.01.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -1.69M
- Pretax Income
- -759.00K
- Net Income
- -6.97M
- EBITDA
- -1.27M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Xtl Bio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -23.92%
- Earnings Yield
- -178.36%
Stock Price Statistics
- Beta
- 0.51
- 52-Week Price Change
- -58.82%
- 50-Day Moving Average
- 1.64
- 200-Day Moving Average
- 2.02
- Relative Strength Index (RSI)
- 40.28
- Average Volume (3m)
- 970.06K
Financial Position
Xtl Bio as a current ratio of 0.40, with Debt / Equity ratio of -105.91%
- Current Ratio
- 0.40
- Quick Ratio
- 0.40
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- -0.15
- Interest Coverage Ratio
- -241.14
Taxes
In the past 12 months, Xtl Bio has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Xtl Bio EV to EBITDA ratio is -3.54, with an EV/FCF ratio of -4.37.
- EV to Sales
- 0.00
- EV to EBITDA
- -3.54
- EV to Free Cash Flow
- -4.37
- EV to Operating Cash Flow
- -4.37
Balance Sheet
Xtl Bio has ILA 259.00K in cash and marketable securities with ILA 86.00K in debt, giving a net cash position of ILA 173.00K billion.
- Cash & Marketable Securities
- ILA 259.00K
- Total Debt
- ILA 86.00K
- Net Cash
- ILA 173.00K
- Net Cash Per Share
- ILA 0.00
- Tangible Book Value Per Share
- ILA 0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Xtl Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―

